跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation) - TGA Drug Approval Details
Approvals
/
TGA
/
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation)
Approved
STANDARD
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation)
Haleon Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
df1a7de03f0263f7
Company
Haleon Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
df1a7de03f0263f7
Product Name
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation)
Artg Id
142197
Artg Name
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1mg/mL pump actuated metered dose aerosol (reformulation)
Sponsor
Haleon Australia Pty Ltd
Company Detail Path
/organization/haleon-australia-pty-ltd
Artg Date
2007-07-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01534-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
df1a7de03f0263f7
Type
Standard
Back to TGA Approvals